Loading organizations...
Loading organizations...
Biotechnology company developing medications in oncology and immunology.
D3 Bio has raised $370.0M across 3 funding rounds.
D3 Bio has raised $370.0M in total across 3 funding rounds.
D3 Bio has raised $370.0M in total across 3 funding rounds.
D3 Bio's investors include IDG Capital, Matrix Partners China, Medicxi, Sequoia Capital, Temasek, WuXi AppTec, Francesco De Rubertis, Yanling Cao, Hongshan Capital Group (Sequoia Capital China).
D3 Bio has raised $370.0M across 3 funding rounds. Most recently, it raised $108.0M Series B in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 10, 2025 | $108.0M Series B | IDG Capital, Matrix Partners China, Medicxi, Sequoia Capital, Temasek, WuXi AppTec | |
| Apr 8, 2024 | $62.0M Series A | Francesco De Rubertis | Matrix Partners China, WuXi AppTec |
| Nov 17, 2020 | $200.0M Series A | Yanling Cao, Hongshan Capital Group (Sequoia Capital China), Matrix Partners China, Temasek, WuXi AppTec |